December 18, 2007 – ProSolv CardioVascular, a Fujifilm company, announced that they have been ranked No. 1 by KLAS in the 2007 Cardiology PACS Study, achieving the highest total score when evaluated on 40 performance indicators, ranking first in 26 of the 40 indicators.

The high score was reportedly reached by ranking first in the majority of the 40 performance indicators, including: commitment to technology, technology easy to implement and support, works with 3rd party vendors, lived up to expectations, helps job performance, and timely enhancement releases. Furthermore, 100 percent of those surveyed said they would buy ProSolv Cardiology PACS again as well as recommend it to a peer.
The company continued to show above average CPACS product functionality in echocardiography, vascular ultrasound and nuclear cardiology, primarily due to by ProSolv's advanced integrations in these subspecialties that are supported by ProSolv's reporting capabilities.
For more information: www.prosolv.com, www.healthcomputing.com


Additional Content

Sponsored Content | Whitepapers | Information Technology

The Interoperability Decision Every Imaging Operation Is Facing Integration protocol has become an operational and ...

Time October 25, 2026
arrow
News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Feature | PACS | John Freeland

People in healthcare technology love to talk about digital transformation like it just started happening. Cloud ...

Time June 29, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
News | Information Technology

June 24, 2026 — HOPPR Presto Agent (Presto) is now commercially available from HOPPR. Presto iis a tool that ntegrates ...

Time June 24, 2026
arrow
Subscribe Now